275 related articles for article (PubMed ID: 21618531)
21. Carrying Excess Baggage Can Slowdown Life: Protein Clearance Machineries That Go Awry During Aging and the Relevance of Maintaining Them.
Sarkar A; Nazir A
Mol Neurobiol; 2022 Feb; 59(2):821-840. PubMed ID: 34792731
[TBL] [Abstract][Full Text] [Related]
22. Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.
van der Putten H; Lotz GP
Neurotherapeutics; 2013 Jul; 10(3):416-28. PubMed ID: 23536253
[TBL] [Abstract][Full Text] [Related]
23. Chaperoning osteogenesis: new protein-folding disease paradigms.
Makareeva E; Aviles NA; Leikin S
Trends Cell Biol; 2011 Mar; 21(3):168-76. PubMed ID: 21183349
[TBL] [Abstract][Full Text] [Related]
24. Protein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.
Pey AL
Amino Acids; 2013 Dec; 45(6):1331-41. PubMed ID: 24178766
[TBL] [Abstract][Full Text] [Related]
25. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
Iram A; Naeem A
Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
[TBL] [Abstract][Full Text] [Related]
26. The Nucleolus as a Proteostasis Regulator.
Amer-Sarsour F; Ashkenazi A
Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
[TBL] [Abstract][Full Text] [Related]
27. Protein-misfolding diseases and the paradigm of proteomics-based therapeutic targets.
Singh OV
Expert Rev Proteomics; 2010 Aug; 7(4):463-4. PubMed ID: 20653501
[No Abstract] [Full Text] [Related]
28. Protein misfolding in disease and small molecule therapies.
Gomes CM
Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
[TBL] [Abstract][Full Text] [Related]
29. Assistance for Folding of Disease-Causing Plasma Membrane Proteins.
Juarez-Navarro K; Ayala-Garcia VM; Ruiz-Baca E; Meneses-Morales I; Rios-Banuelos JL; Lopez-Rodriguez A
Biomolecules; 2020 May; 10(5):. PubMed ID: 32392767
[TBL] [Abstract][Full Text] [Related]
30. Chaperone networks: tipping the balance in protein folding diseases.
Voisine C; Pedersen JS; Morimoto RI
Neurobiol Dis; 2010 Oct; 40(1):12-20. PubMed ID: 20472062
[TBL] [Abstract][Full Text] [Related]
31. The role of cellular proteostasis in antitumor immunity.
Mercier R; LaPointe P
J Biol Chem; 2022 May; 298(5):101930. PubMed ID: 35421375
[TBL] [Abstract][Full Text] [Related]
32. Biological and chemical approaches to diseases of proteostasis deficiency.
Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
[TBL] [Abstract][Full Text] [Related]
33. Protein folding disorders: toward a basic biological paradigm.
Wallace R
J Theor Biol; 2010 Dec; 267(4):582-94. PubMed ID: 20858502
[TBL] [Abstract][Full Text] [Related]
34. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.
Saxena S; Caroni P
Neuron; 2011 Jul; 71(1):35-48. PubMed ID: 21745636
[TBL] [Abstract][Full Text] [Related]
35. Pathways of cellular proteostasis in aging and disease.
Klaips CL; Jayaraj GG; Hartl FU
J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
[TBL] [Abstract][Full Text] [Related]
36. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
[TBL] [Abstract][Full Text] [Related]
37. Roles of the nucleotide exchange factor and chaperone Hsp110 in cellular proteostasis and diseases of protein misfolding.
Yakubu UM; Morano KA
Biol Chem; 2018 Sep; 399(10):1215-1221. PubMed ID: 29908125
[TBL] [Abstract][Full Text] [Related]
38. Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.
Ong DS; Kelly JW
Curr Opin Cell Biol; 2011 Apr; 23(2):231-8. PubMed ID: 21146391
[TBL] [Abstract][Full Text] [Related]
39. Chaperone networks are shaped by cellular differentiation and identity.
Nisaa K; Ben-Zvi A
Trends Cell Biol; 2022 Jun; 32(6):470-474. PubMed ID: 34863585
[TBL] [Abstract][Full Text] [Related]
40. Towards novel paradigms for cancer therapy.
Pavet V; Portal MM; Moulin JC; Herbrecht R; Gronemeyer H
Oncogene; 2011 Jan; 30(1):1-20. PubMed ID: 20935674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
